Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Gains from Investment Securities (2016 - 2025)

Marimed has reported Gains from Investment Securities over the past 12 years, most recently at $1.6 million for Q4 2025.

  • Quarterly Gains from Investment Securities fell 63.8% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 54.29% year-over-year, with the annual reading at $1.3 million for FY2025, 54.29% down from the prior year.
  • Gains from Investment Securities was $1.6 million for Q4 2025 at Marimed, up from -$3.2 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $11.8 million in Q2 2022 and troughed at -$11.9 million in Q3 2022.
  • The 5-year median for Gains from Investment Securities is $392500.0 (2021), against an average of $434400.0.
  • The largest YoY upside for Gains from Investment Securities was 295450.0% in 2022 against a maximum downside of 4059.0% in 2022.
  • A 5-year view of Gains from Investment Securities shows it stood at -$17000.0 in 2021, then soared by 5711.76% to $954000.0 in 2022, then fell by 2.94% to $926000.0 in 2023, then soared by 365.98% to $4.3 million in 2024, then crashed by 63.8% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Gains from Investment Securities are $1.6 million (Q4 2025), -$3.2 million (Q3 2025), and $3.0 million (Q2 2025).